The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Vaccine Contract Manufacturing-Global Market Insights and Sales Trends 2024
Synopsis
The global Vaccine Contract Manufacturing market size is expected to reach US$ 2558.5 million by 2029, growing at a CAGR of 5.3% from 2023 to 2029. The market is mainly driven by the significant applications of Vaccine Contract Manufacturing in various end use industries. The expanding demands from the Pharmaceutical Companies, Biotech Companies and Others,, are propelling Vaccine Contract Manufacturing market. Fill-Finish, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Bulk Product segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Vaccine Contract Manufacturing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Vaccine Contract Manufacturing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Vaccine Contract Manufacturing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Vaccine Contract Manufacturing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Vaccine Contract Manufacturing covered in this report include Diosynth, Emergent BioSolutions, Goodwin Biotechnology, Bavarian Nordic, Soligenix Inc and Catalent Biologics, etc.
The global Vaccine Contract Manufacturing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Diosynth
Emergent BioSolutions
Goodwin Biotechnology
Bavarian Nordic
Soligenix Inc
Catalent Biologics
Global Vaccine Contract Manufacturing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Vaccine Contract Manufacturing market, Segment by Type:
Fill-Finish
Bulk Product
Global Vaccine Contract Manufacturing market, by Application
Pharmaceutical Companies
Biotech Companies
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Vaccine Contract Manufacturing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Vaccine Contract Manufacturing market size is expected to reach US$ 2558.5 million by 2029, growing at a CAGR of 5.3% from 2023 to 2029. The market is mainly driven by the significant applications of Vaccine Contract Manufacturing in various end use industries. The expanding demands from the Pharmaceutical Companies, Biotech Companies and Others,, are propelling Vaccine Contract Manufacturing market. Fill-Finish, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Bulk Product segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Vaccine Contract Manufacturing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Vaccine Contract Manufacturing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Vaccine Contract Manufacturing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Vaccine Contract Manufacturing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Vaccine Contract Manufacturing covered in this report include Diosynth, Emergent BioSolutions, Goodwin Biotechnology, Bavarian Nordic, Soligenix Inc and Catalent Biologics, etc.
The global Vaccine Contract Manufacturing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Diosynth
Emergent BioSolutions
Goodwin Biotechnology
Bavarian Nordic
Soligenix Inc
Catalent Biologics
Global Vaccine Contract Manufacturing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Vaccine Contract Manufacturing market, Segment by Type:
Fill-Finish
Bulk Product
Global Vaccine Contract Manufacturing market, by Application
Pharmaceutical Companies
Biotech Companies
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Vaccine Contract Manufacturing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Vaccine Contract Manufacturing
1.1 Vaccine Contract Manufacturing Market Overview
1.1.1 Vaccine Contract Manufacturing Product Scope
1.1.2 Vaccine Contract Manufacturing Market Status and Outlook
1.2 Global Vaccine Contract Manufacturing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Vaccine Contract Manufacturing Market Size by Region (2018-2029)
1.4 Global Vaccine Contract Manufacturing Historic Market Size by Region (2018-2023)
1.5 Global Vaccine Contract Manufacturing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Vaccine Contract Manufacturing Market Size (2018-2029)
1.6.1 North America Vaccine Contract Manufacturing Market Size (2018-2029)
1.6.2 Europe Vaccine Contract Manufacturing Market Size (2018-2029)
1.6.3 Asia-Pacific Vaccine Contract Manufacturing Market Size (2018-2029)
1.6.4 Latin America Vaccine Contract Manufacturing Market Size (2018-2029)
1.6.5 Middle East & Africa Vaccine Contract Manufacturing Market Size (2018-2029)
2 Vaccine Contract Manufacturing Market by Type
2.1 Introduction
2.1.1 Fill-Finish
2.1.2 Bulk Product
2.2 Global Vaccine Contract Manufacturing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Vaccine Contract Manufacturing Historic Market Size by Type (2018-2023)
2.2.2 Global Vaccine Contract Manufacturing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Vaccine Contract Manufacturing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Vaccine Contract Manufacturing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Vaccine Contract Manufacturing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Vaccine Contract Manufacturing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Vaccine Contract Manufacturing Revenue Breakdown by Type (2018-2029)
3 Vaccine Contract Manufacturing Market Overview by Application
3.1 Introduction
3.1.1 Pharmaceutical Companies
3.1.2 Biotech Companies
3.1.3 Others
3.2 Global Vaccine Contract Manufacturing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Vaccine Contract Manufacturing Historic Market Size by Application (2018-2023)
3.2.2 Global Vaccine Contract Manufacturing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Vaccine Contract Manufacturing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Vaccine Contract Manufacturing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Vaccine Contract Manufacturing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Vaccine Contract Manufacturing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Vaccine Contract Manufacturing Revenue Breakdown by Application (2018-2029)
4 Vaccine Contract Manufacturing Competition Analysis by Players
4.1 Global Vaccine Contract Manufacturing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Vaccine Contract Manufacturing as of 2022)
4.3 Date of Key Players Enter into Vaccine Contract Manufacturing Market
4.4 Global Top Players Vaccine Contract Manufacturing Headquarters and Area Served
4.5 Key Players Vaccine Contract Manufacturing Product Solution and Service
4.6 Competitive Status
4.6.1 Vaccine Contract Manufacturing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Diosynth
5.1.1 Diosynth Profile
5.1.2 Diosynth Main Business
5.1.3 Diosynth Vaccine Contract Manufacturing Products, Services and Solutions
5.1.4 Diosynth Vaccine Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.1.5 Diosynth Recent Developments
5.2 Emergent BioSolutions
5.2.1 Emergent BioSolutions Profile
5.2.2 Emergent BioSolutions Main Business
5.2.3 Emergent BioSolutions Vaccine Contract Manufacturing Products, Services and Solutions
5.2.4 Emergent BioSolutions Vaccine Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.2.5 Emergent BioSolutions Recent Developments
5.3 Goodwin Biotechnology
5.3.1 Goodwin Biotechnology Profile
5.3.2 Goodwin Biotechnology Main Business
5.3.3 Goodwin Biotechnology Vaccine Contract Manufacturing Products, Services and Solutions
5.3.4 Goodwin Biotechnology Vaccine Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.3.5 Bavarian Nordic Recent Developments
5.4 Bavarian Nordic
5.4.1 Bavarian Nordic Profile
5.4.2 Bavarian Nordic Main Business
5.4.3 Bavarian Nordic Vaccine Contract Manufacturing Products, Services and Solutions
5.4.4 Bavarian Nordic Vaccine Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.4.5 Bavarian Nordic Recent Developments
5.5 Soligenix Inc
5.5.1 Soligenix Inc Profile
5.5.2 Soligenix Inc Main Business
5.5.3 Soligenix Inc Vaccine Contract Manufacturing Products, Services and Solutions
5.5.4 Soligenix Inc Vaccine Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.5.5 Soligenix Inc Recent Developments
5.6 Catalent Biologics
5.6.1 Catalent Biologics Profile
5.6.2 Catalent Biologics Main Business
5.6.3 Catalent Biologics Vaccine Contract Manufacturing Products, Services and Solutions
5.6.4 Catalent Biologics Vaccine Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.6.5 Catalent Biologics Recent Developments
6 North America
6.1 North America Vaccine Contract Manufacturing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Vaccine Contract Manufacturing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Vaccine Contract Manufacturing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Vaccine Contract Manufacturing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Vaccine Contract Manufacturing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Vaccine Contract Manufacturing Market Dynamics
11.1 Vaccine Contract Manufacturing Industry Trends
11.2 Vaccine Contract Manufacturing Market Drivers
11.3 Vaccine Contract Manufacturing Market Challenges
11.4 Vaccine Contract Manufacturing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
